A Win For Vaxcyte Inc.

Mon, Oct 24, 2022 at 07:35 PM

Vaxcyte Inc. (PCVX:NASDAQ) soared at $33, a gain of 60.3%. On Mon, Oct 24, 2022, PCVX:NASDAQ touched a New 2-Week High of $33. The stock appeared on our News Catalysts scanner on Mon, Oct 24, 2022 at 06:59 PM in the 'BIOTECH' category. From Mon, Oct 10, 2022, the stock recorded 50.00% Up Days and 45.45% Green Days

About Vaxcyte Inc. (PCVX:NASDAQ)

Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises.

Top 10 Gainers:

Applied Genetic Technologies Corporation (AGTC:NASDAQ), 62.43%
Vaxcyte Inc. (PCVX:NASDAQ), 60.35%
Mullen Automotive Inc. (MULN:NASDAQ), 32.94%
Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 24.76%
Motus GI Holdings, Inc. (MOTS:NASDAQ), 23.13%
NOVONIX Limited (NVX:NASDAQ), 22.1%
BYND Cannasoft Enterprises Inc. (BCAN:NASDAQ), 20.6%
Dermata Therapeutics Inc. (DRMA:NASDAQ), 18.1%
uCloudlink Group Inc. (UCL:NASDAQ), 16.96%
Elite Education Group International Ltd. (EEIQ:NASDAQ), 16.7%